FDA’s presence in Europe greatly facilitates and enhances the large body of work on which FDA currently collaborates with its European counterpart agencies. The Europe Office’s activities with the European Commission (EC) include extensive regulatory cooperation on all products that FDA regulates, i.e., cosmetics, drugs, biological products, food, medical devices, and veterinary medical products. The European Medicines Agency (EMA) is one of FDA’s closest regulatory partners in the area of medical product review. FDA maintains an active robust bilateral relationship with EMA, along with national regulatory authorities throughout Europe. Confidentiality arrangements facilitate information exchange with the EC, EMA, and European Food Safety Authority (EFSA), and at the national level with Austria, Belgium, Denmark, France, Germany, Ireland, Italy, The Netherlands, Sweden, Switzerland, and the United Kingdom. FDA’s Europe Office works closely with other U.S. government agencies in Europe, as well as with industry, multilateral organizations, and consumer groups on the public health issues of importance to FDA.
Europe Office staff is located at the FDA headquarters in Silver Spring, Maryland, at the EMA in London, England and at the EFSA, located in Parma, Italy.